ENSC vs BFRI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ENSC Captures Institutional Edge (2โ1 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ensysce Biosciences, Inc. Common Stock (ENSC) driven by superior Valuation, Momentum & Technical while BFRI counters with relative strength in Growth & Margin. Fundamentally, ENSC trades at 0.8x Forward P/E with -281.3% operating margin (-15.1% YoY revenue) versus BFRI at 13.0x Forward P/E and -12.6% operating margin (+29.8% YoY). In options structure, ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BFRI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ENSC Revenue | BFRI Revenue | ENSC Op. Margin | BFRI Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2020 | $0M | $20M | -41.0% | -51.0% | ENSC |
| FY2021 | $0M | $20M | -562.7% | -104.6% | BFRI |
| FY2022 | $0M | $30M | -959.9% | -64.8% | BFRI |
| FY2023 | $0M | $30M | -480.5% | -66.6% | BFRI |
| FY2024 | $10M | $40M | -129.2% | -46.1% | BFRI |
| FY2025 | $10M | $40M | -202.1% | -27.2% | BFRI |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ENSC | BFRI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.0M | $10.2M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 0.8x | 13.0x | Lower Multiple | ENSC |
| Forward P/E Ratio Valuation | 0.8x | 13.0x | Lower Multiple | ENSC |
| Revenue Growth (YoY) Growth | -15.1% | +29.8% | Higher Growth | BFRI |
| Operating Margin (TTM) Profitability | -281.3% | -12.6% | Higher Margin | BFRI |
| Net Profit Margin Profitability | -280.5% | -12.7% | Higher Margin | BFRI |
| Return on Equity (ROE) Capital Efficiency | -1295.1% | -988.4% | Higher ROE | BFRI |
| 52-Week Range Position Momentum | 8% ($0โ$2) | 0% ($1โ$2) | Stronger Trend | ENSC |
| Beta / 30D Volatility Risk Regime | 0.98ฮฒ ยท 79% Vol | 1.84ฮฒ ยท 125% Vol | Lower Realized Risk | ENSC |
| Unified Institutional Score Composite Signal | 53.4 / 100 (HOLD) | 44.0 / 100 (HOLD) | Higher Composite | ENSC |